3,7-DIHYDRO-7-(4-HYDROXY-2-BUTYN-1-YL)-8-((3S)-3-HYDROXY-1-PIPERIDINYL)-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-1H-PURINE-2,6-DIONE
UNII E443NQ9ZNX
Substance Identification & Data
This profile provides standardized clinical and technical data for 3,7-dihydro-7-(4-hydroxy-2-butyn-1-yl)-8-((3s)-3-hydroxy-1-piperidinyl)-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E443NQ9ZNX.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1297273-96-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H27N7O4 DGVYUAILSQZNGN-KRWDZBQOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3,7-dihydro-7-(4-hydroxy-2-butyn-1-yl)-8-((3s)-3-hydroxy-1-piperidinyl)-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.